# Diversified Healthcare Trust: financial statements, quarterly

DHC · Nasdaq · CIK 1075415 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dhc.md) · [Financials](/companies/dhc/financials.md) · [Filings](/companies/dhc/filings.md) · [Insiders](/companies/dhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dhc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [357](/filings/0001075415-24-000031.md) | [362 d](/filings/0001075415-26-000013.md) | [371](/filings/0001075415-25-000024.md) | [371](/filings/0001075415-25-000033.md) | [374](/filings/0001075415-25-000044.md) | [380 d](/filings/0001075415-26-000013.md) | [387](/filings/0001075415-26-000024.md) | [383](/filings/0001075415-26-000030.md) | [389](/filings/0001075415-25-000044.md) | [380 d](/filings/0001075415-26-000013.md) | [366](/filings/0001075415-26-000024.md) | [365](/filings/0001075415-26-000030.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [47.8](/filings/0001075415-24-000031.md) | [48.9 d](/filings/0001075415-24-000007.md) | [57.6](/filings/0001075415-24-000015.md) | [58.7](/filings/0001075415-24-000023.md) | [59.4](/filings/0001075415-24-000031.md) | [59.5 d](/filings/0001075415-26-000013.md) | [57.8](/filings/0001075415-26-000024.md) | [50.9](/filings/0001075415-26-000030.md) | [48.9](/filings/0001075415-25-000044.md) | [46.9 d](/filings/0001075415-26-000013.md) | [37.0](/filings/0001075415-26-000024.md) | [37.1](/filings/0001075415-26-000030.md) |
| Income tax | $m | [0.2](/filings/0001075415-24-000031.md) | [0.1 d](/filings/0001075415-26-000013.md) | [0.2](/filings/0001075415-25-000024.md) | [0.2](/filings/0001075415-25-000033.md) | [0.1](/filings/0001075415-25-000044.md) | [(0.0) d](/filings/0001075415-26-000013.md) | [0.0](/filings/0001075415-26-000024.md) | [0.8](/filings/0001075415-26-000030.md) | [0.3](/filings/0001075415-25-000044.md) | [0.5 d](/filings/0001075415-26-000013.md) | [0.6](/filings/0001075415-26-000024.md) | [1.3](/filings/0001075415-26-000030.md) |
| Net income | $m | [(65.8)](/filings/0001075415-24-000031.md) | [(103) d](/filings/0001075415-26-000013.md) | [(86.3)](/filings/0001075415-25-000044.md) | [(97.9)](/filings/0001075415-25-000044.md) | [(98.7)](/filings/0001075415-25-000044.md) | [(87.4) d](/filings/0001075415-26-000013.md) | [(9.0)](/filings/0001075415-26-000030.md) | [(91.6)](/filings/0001075415-26-000030.md) | [(164)](/filings/0001075415-25-000044.md) | [(21.2) d](/filings/0001075415-26-000013.md) | [(43.3)](/filings/0001075415-26-000030.md) | [(37.4)](/filings/0001075415-26-000030.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001075415-24-000031.md) | not reported | [(0.36)](/filings/0001075415-25-000024.md) | [(0.41)](/filings/0001075415-25-000033.md) | [(0.41)](/filings/0001075415-25-000044.md) | not reported | [(0.04)](/filings/0001075415-26-000024.md) | [(0.38)](/filings/0001075415-26-000030.md) | [(0.68)](/filings/0001075415-25-000044.md) | not reported | [(0.18)](/filings/0001075415-26-000024.md) | [(0.16)](/filings/0001075415-26-000030.md) |
| Basic EPS | $ per share | [(0.28)](/filings/0001075415-24-000031.md) | not reported | [(0.36)](/filings/0001075415-25-000024.md) | [(0.41)](/filings/0001075415-25-000033.md) | [(0.41)](/filings/0001075415-25-000044.md) | not reported | [(0.04)](/filings/0001075415-26-000024.md) | [(0.38)](/filings/0001075415-26-000030.md) | [(0.68)](/filings/0001075415-25-000044.md) | not reported | [(0.18)](/filings/0001075415-26-000024.md) | [(0.16)](/filings/0001075415-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [278](/filings/0001075415-24-000031.md) | [246](/filings/0001075415-26-000013.md) | [207](/filings/0001075415-25-000024.md) | [266](/filings/0001075415-25-000033.md) | [257](/filings/0001075415-25-000044.md) | [145](/filings/0001075415-26-000013.md) | [303](/filings/0001075415-26-000024.md) | [142](/filings/0001075415-26-000030.md) | [201](/filings/0001075415-25-000044.md) | [105](/filings/0001075415-26-000030.md) | [122](/filings/0001075415-26-000024.md) | [117](/filings/0001075415-26-000030.md) |
| Total assets | $m | [5,530](/filings/0001075415-23-000035.md) | [5,446](/filings/0001075415-26-000013.md) | [5,348](/filings/0001075415-24-000015.md) | [5,333](/filings/0001075415-24-000023.md) | [5,285](/filings/0001075415-24-000031.md) | [5,137](/filings/0001075415-26-000013.md) | [4,996](/filings/0001075415-25-000024.md) | [4,756](/filings/0001075415-25-000033.md) | [4,684](/filings/0001075415-25-000044.md) | [4,361](/filings/0001075415-26-000030.md) | [4,268](/filings/0001075415-26-000024.md) | [4,239](/filings/0001075415-26-000030.md) |
| Total liabilities | $m | [3,089](/filings/0001075415-23-000035.md) | [3,109](/filings/0001075415-25-000012.md) | [3,099](/filings/0001075415-24-000015.md) | [3,184](/filings/0001075415-24-000023.md) | [3,237](/filings/0001075415-24-000031.md) | [3,178](/filings/0001075415-26-000013.md) | [3,048](/filings/0001075415-25-000024.md) | [2,901](/filings/0001075415-25-000033.md) | [2,995](/filings/0001075415-25-000044.md) | [2,696](/filings/0001075415-26-000030.md) | [2,647](/filings/0001075415-26-000024.md) | [2,656](/filings/0001075415-26-000030.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [3,050](/filings/0001075415-25-000012.md) | not reported | not reported | not reported | [2,444](/filings/0001075415-26-000013.md) | [2,443](/filings/0001075415-26-000024.md) | [2,442](/filings/0001075415-26-000030.md) |
| Current portion of debt | $m | [700](/filings/0001075415-23-000035.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,442](/filings/0001075415-24-000031.md) | [2,337](/filings/0001075415-26-000013.md) | [2,249](/filings/0001075415-25-000044.md) | [2,149](/filings/0001075415-25-000044.md) | [2,048](/filings/0001075415-25-000044.md) | [1,959](/filings/0001075415-26-000030.md) | [1,948](/filings/0001075415-26-000030.md) | [1,855](/filings/0001075415-26-000030.md) | [1,689](/filings/0001075415-25-000044.md) | [1,666](/filings/0001075415-26-000030.md) | [1,620](/filings/0001075415-26-000030.md) | [1,583](/filings/0001075415-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.0) d](/filings/0001075415-24-000031.md) | [(7.2) d](/filings/0001075415-26-000013.md) | [28.6](/filings/0001075415-25-000024.md) | [44.3 d](/filings/0001075415-25-000033.md) | [21.1 d](/filings/0001075415-25-000044.md) | [18.2 d](/filings/0001075415-26-000013.md) | [(3.2)](/filings/0001075415-26-000024.md) | [53.0 d](/filings/0001075415-26-000030.md) | [(49.3) d](/filings/0001075415-25-000044.md) | [(20.1) d](/filings/0001075415-26-000013.md) | [8.3](/filings/0001075415-26-000024.md) | [38.4 d](/filings/0001075415-26-000030.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [2.4 d](/filings/0001075415-24-000031.md) | [2.4 d](/filings/0001075415-26-000013.md) | [2.4](/filings/0001075415-25-000024.md) | [2.4 d](/filings/0001075415-25-000033.md) | [2.4 d](/filings/0001075415-25-000044.md) | [2.4 d](/filings/0001075415-26-000013.md) | [2.4](/filings/0001075415-26-000024.md) | [2.4 d](/filings/0001075415-26-000030.md) | [2.4 d](/filings/0001075415-25-000044.md) | [2.4 d](/filings/0001075415-26-000013.md) | [2.4](/filings/0001075415-26-000024.md) | [2.4 d](/filings/0001075415-26-000030.md) |
| Share repurchases | $m | [0.4 d](/filings/0001075415-24-000031.md) | [0.0 d](/filings/0001075415-26-000013.md) | [0.1](/filings/0001075415-25-000024.md) | [0.0 d](/filings/0001075415-25-000033.md) | [0.8 d](/filings/0001075415-25-000044.md) | [0.0 d](/filings/0001075415-26-000013.md) | [0.0](/filings/0001075415-26-000024.md) | [0.1 d](/filings/0001075415-26-000030.md) | [1.0 d](/filings/0001075415-25-000044.md) | [0.1 d](/filings/0001075415-26-000013.md) | [0.1](/filings/0001075415-26-000024.md) | [0.1 d](/filings/0001075415-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [238](/filings/0001075415-23-000035.md) | [239](/filings/0001075415-24-000015.md) | [239](/filings/0001075415-24-000023.md) | [239](/filings/0001075415-24-000031.md) | [239](/filings/0001075415-25-000024.md) | [239](/filings/0001075415-25-000033.md) | [240](/filings/0001075415-25-000044.md) | [240](/filings/0001075415-26-000024.md) | [240](/filings/0001075415-26-000030.md) | [240](/filings/0001075415-25-000044.md) | [241](/filings/0001075415-26-000024.md) | [241](/filings/0001075415-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 242,128,988 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001075415-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.